ACM
QDEL icon

ACT Capital Management’s QuidelOrtho QDEL Stock Holding History

ACT Capital Management’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$141K – 108
2021
Q3 		$141K Sell
1,000
-5,100
-84% -$686K 0.07% 87
2021
Q2 		$782K Buy
+6,100
New +$718K 0.4% 46

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

ACT Capital Management's QDEL Position: Q4 2021 in Review

ACT Capital Management sold out of QuidelOrtho (QDEL) in Q4 2021, closing a stake of 1,000 shares — an estimated $141K sold.

ACT Capital Management first reported a position in QDEL in Q2 2021 and held it in 2 quarters. The position peaked at $782K in Q2 2021. 361 funds tracked by Wall St. Rank hold QDEL as of Q4 2021.

  • ACT Capital Management reported no remaining QuidelOrtho position as of Q4 2021 after selling out during the quarter.
  • ACT Capital Management sold 1,000 QuidelOrtho shares in Q4 2021, an estimated $141K.
  • ACT Capital Management first reported a position in QuidelOrtho in Q2 2021 and held it in 2 quarters.
  • ACT Capital Management's QuidelOrtho position peaked at $782K in Q2 2021.
  • 361 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2021.

Based on ACT Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.